Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II multicenter trial combining nivolumab and radiosurgery for NSCLC and RCC brain metastases.
Wong P, Masucci L, Florescu M, Plourde ME, Panet-Raymond V, Pavic M, Owen S, Masson-Coté L, Ménard C, Routy B, Tehfe M, Nelson K, Guilbert F, Boucher O, Keshavarzi S, Blais N, Roberge D. Wong P, et al. Among authors: plourde me. Neurooncol Adv. 2023 Mar 1;5(1):vdad018. doi: 10.1093/noajnl/vdad018. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 37025758 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 34701783
[In patients with heart failure with preserved or mildly reduced ejection fraction, is finerenone effective in reducing a composite of heart failure exacerbation and cardiovascular death compared to placebo, and is it safe?].
Lanthier L, Mutchmore A, Plourde MÉ, Cauchon M. Lanthier L, et al. Among authors: plourde me. Rev Med Interne. 2025 Jan;46(1):57-58. doi: 10.1016/j.revmed.2024.11.007. Epub 2024 Nov 19. Rev Med Interne. 2025. PMID: 39567335 French. No abstract available.
[In mechanically ventilated adult patients admitted to intensive care, does the use of pantoprazole for prophylaxis reduce the risk of gastrointestinal bleeding compared to placebo, and is it safe?].
Lanthier L, Mayette M, Mutchmore A, Plourde MÉ, Cauchon M. Lanthier L, et al. Among authors: plourde me. Rev Med Interne. 2024 Dec;45(12):787-788. doi: 10.1016/j.revmed.2024.10.010. Epub 2024 Oct 29. Rev Med Interne. 2024. PMID: 39477778 French. No abstract available.
[Among patients with type 2 diabetes and chronic kidney disease, does semaglutide prevent end-stage renal disease, significant loss of kidney function, or death from renal or cardiovascular causes compared to placebo, and is it safe?].
Lanthier L, Mutchmore A, Plourde MÉ, Cauchon M. Lanthier L, et al. Among authors: plourde me. Rev Med Interne. 2024 Oct;45(10):667-668. doi: 10.1016/j.revmed.2024.07.011. Epub 2024 Aug 10. Rev Med Interne. 2024. PMID: 39129120 French. No abstract available.
[Among patients with acute myocardial infarction who had undergone coronary angiography and with preserved left ventricular ejection fraction, does long-term beta-blocker therapy lower the risk of death or recurrent myocardial infarction?].
Lanthier L, Plourde MÉ, Cauchon M. Lanthier L, et al. Among authors: plourde me. Rev Med Interne. 2024 Jul;45(7):453-454. doi: 10.1016/j.revmed.2024.05.024. Epub 2024 Jun 6. Rev Med Interne. 2024. PMID: 38845251 French. No abstract available.
41 results